Back to Journals » Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy » Volume 2

Review

Alogliptin: a new addition to the class of DPP-4 inhibitors

      
Total article views   HTML views PDF downloads Totals
19,103 Dovepress* 19,103+ 6,034 25,137
Totals 19,103 6,034 25,137
*Since 21 July 2009
+Since July 2016

View citations on Google Scholar